Cholesterol in ASD_Laboratory Dataset in Cholesterol in Autism Spectrum Disorder (ASD): Characterization and Treatment

Hematology and chemistry laboratory results, including total, HDL, and LDL cholesterol, on 42 children with Autism Spectrum Disorder (ASD)
Study Description
Initially designed as a randomized, double-blind, placebo-controlled clinical trial for children with autism spectrum disorder (ASD), enrollment ceased early due to lack of funding for extramural collaborators. One of the primary aims of the study was to establish the prevalence of hypocholesterolemia and hypercholesterolemia in idiopathic ASD. Available in DASH are laboratory results collected at multiple time points, including cholesterol levels, on 42 children enrolled during the first three years of the study
Children 4 to 12 years of age with Autism Spectrum Disorder